Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

351 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Are hybrid conferences the new standard?
Baumann M, Bacchus C, Aznar MC, Coppes RP, Deutsch E, Georg D, Haustermans K, Hoskin P, Krause M, Lartigau EF, Lee AWM, Löck S, Offersen BV, Overgaard J, Thwaites DI, van der Kogel AJ, van der Heide UA, Valentini V. Baumann M, et al. Among authors: haustermans k. Radiother Oncol. 2023 Jul;184:109695. doi: 10.1016/j.radonc.2023.109695. Epub 2023 May 6. Radiother Oncol. 2023. PMID: 37150445 No abstract available.
The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis.
Begg AC, Haustermans K, Hart AA, Dische S, Saunders M, Zackrisson B, Gustaffson H, Coucke P, Paschoud N, Hoyer M, Overgaard J, Antognoni P, Richetti A, Bourhis J, Bartelink H, Horiot JC, Corvo R, Giaretti W, Awwad H, Shouman T, Jouffroy T, Maciorowski Z, Dobrowsky W, Struikmans H, Wilson GD, et al. Begg AC, et al. Among authors: haustermans k. Radiother Oncol. 1999 Jan;50(1):13-23. doi: 10.1016/s0167-8140(98)00147-9. Radiother Oncol. 1999. PMID: 10225552 Free article.
Thymidine analogues to assess microperfusion in human tumors.
Janssen HL, Ljungkvist AS, Rijken PF, Sprong D, Bussink J, van der Kogel AJ, Haustermans KM, Begg AC. Janssen HL, et al. Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1169-75. doi: 10.1016/j.ijrobp.2005.03.063. Int J Radiat Oncol Biol Phys. 2005. PMID: 15990022
IGRT in rectal cancer.
Ippolito E, Mertens I, Haustermans K, Gambacorta MA, Pasini D, Valentini V. Ippolito E, et al. Among authors: haustermans k. Acta Oncol. 2008;47(7):1317-24. doi: 10.1080/02841860802256459. Acta Oncol. 2008. PMID: 18661433 Review.
Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2).
Valentini V, Aristei C, Glimelius B, Minsky BD, Beets-Tan R, Borras JM, Haustermans K, Maingon P, Overgaard J, Pahlman L, Quirke P, Schmoll HJ, Sebag-Montefiore D, Taylor I, Van Cutsem E, Van de Velde C, Cellini N, Latini P; Scientific Committee. Valentini V, et al. Among authors: haustermans k. Radiother Oncol. 2009 Aug;92(2):148-63. doi: 10.1016/j.radonc.2009.06.027. Radiother Oncol. 2009. PMID: 19595467
First report on the patient database for the identification of the genetic pathways involved in patients over-reacting to radiotherapy: GENEPI-II.
De Ruysscher D, Severin D, Barnes E, Baumann M, Bristow R, Grégoire V, Hölscher T, Veninga T, Polański A, van Veen EB, Verfaillie C, Heeren G, Damaraju S, Just U, Haustermans K. De Ruysscher D, et al. Among authors: haustermans k. Radiother Oncol. 2010 Oct;97(1):36-9. doi: 10.1016/j.radonc.2010.03.012. Epub 2010 Mar 24. Radiother Oncol. 2010. PMID: 20338650
Development and external validation of a predictive model for pathological complete response of rectal cancer patients including sequential PET-CT imaging.
van Stiphout RG, Lammering G, Buijsen J, Janssen MH, Gambacorta MA, Slagmolen P, Lambrecht M, Rubello D, Gava M, Giordano A, Postma EO, Haustermans K, Capirci C, Valentini V, Lambin P. van Stiphout RG, et al. Among authors: haustermans k. Radiother Oncol. 2011 Jan;98(1):126-33. doi: 10.1016/j.radonc.2010.12.002. Epub 2010 Dec 20. Radiother Oncol. 2011. PMID: 21176986
Single blind randomized phase III trial to investigate the benefit of a focal lesion ablative microboost in prostate cancer (FLAME-trial): study protocol for a randomized controlled trial.
Lips IM, van der Heide UA, Haustermans K, van Lin EN, Pos F, Franken SP, Kotte AN, van Gils CH, van Vulpen M. Lips IM, et al. Among authors: haustermans k. Trials. 2011 Dec 5;12:255. doi: 10.1186/1745-6215-12-255. Trials. 2011. PMID: 22141598 Free PMC article. Clinical Trial.
351 results